SIK Activators to Treat PTH Pathway Bone Diseases
SIK 激活剂治疗 PTH 通路骨疾病
基本信息
- 批准号:10811083
- 负责人:
- 金额:$ 38.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-19 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAreaAutopsyBindingBiochemicalBiomechanicsBone DiseasesCalvariaCellsCollagenContinuous InfusionCyclic AMPCyclic AMP-Dependent Protein KinasesCytoplasmDataDependenceDevelopmentDiseaseDoseDysplasiaEnzymesFemaleGTP-Binding Protein alpha Subunits, GsGene ExpressionGenesGenetic DiseasesGenetic TranscriptionGoalsHDAC4 geneHDAC5 geneHistone DeacetylaseHyperactivityHyperparathyroidismInjectionsMcCune-Albright SyndromeMeasuresMediatingMessenger RNAMetaphyseal chondrodysplasiaModelingMusNuclear TranslocationOperative Surgical ProceduresOralOsteoblastsOsteoclastsOther GeneticsPTH geneParathyroid Hormone ReceptorPathway interactionsPatientsPhenotypePhosphorylationPhosphorylation InhibitionPhosphotransferasesProteinsRegulationResearchScreening procedureSignal PathwaySkeletonTailTamoxifenTestingTimeTranscription CoactivatorWild Type MouseWorkbonebone turnovercortical bonecraniumdrug discoveryexperimental studyin vivoknock-downlong bonemouse modelpalliativeparathyroid hormone (1-34)preclinical studyresponsesalt-inducible kinaseskeletal disordersmall moleculespine bone structuresubstantia spongiosa
项目摘要
An overactive Parathyroid Hormone Receptor 1 (PTHR1) and its downstream signaling pathway (Gsα) are
involved in several bone diseases including hyperparathyroidism, Jansen’s metaphyseal chondrodysplasia
(due to a constitutively active PTHR1) or Fibrous Dysplasia-McCune-Albright Syndrome (due to a constitutively
active Gsα) which, in the case of the genetic diseases, can cause major developmental and lifelong problems
with their skeletons. In all three situations, the only therapies available are surgical or palliative. Protein Kinase
A (PKA) is an enzyme whose activity is dependent on the activity of Gsα and cellular levels of cAMP. It is
regulated by PTH binding to PTHR1 in osteoblasts. We have generated an inducible, osteoblast-specific
mouse model of hyperactive PKA by collagen 1-directed deletion of the regulatory subunit, Prkar1a, and found
a high bone turnover phenotype in skulls, long bones, vertebrae and caudal bones of the tail that mimics the
PTHR1 diseases. We and others have shown that PTH action on the osteoblast through PKA controls gene
expression, in part, through inhibition by phosphorylation of salt-inducible kinases (SIKs). These kinases
tonically phosphorylate cAMP-regulated transcriptional coactivators (CRTC1, 2 and 3) and histone
deacetylases 4/5 (HDAC4/5), sequestering them in the cytoplasm. Upon PTH action, PKA-mediated SIK
inhibition causes CRTC2 and HDAC4/5 phosphorylation levels to decrease with subsequent nuclear
translocation of CRTC2/3 and HDAC4/5 which mediates transcription of the osteoclastogenic gene, Rankl,
regulation of Mmp13 and suppression of Sost transcription. SIK inhibition, deletion or knockdown mimics the
effects of PTH. We have recently tested several agents for possible activation of the SIKs and resultant
inhibition of PTH-induced Rankl transcription in differentiating mouse calvarial osteoblasts and found a small
molecule, 9117014, as a “putative” SIK activator, to fit these goals. From these data of cells in culture and
preliminary data in vivo, we have developed the hypothesis that small molecule activators of SIKs will reverse
the unwanted effects of the PTH signaling pathway in bone. Consequently, the specific aims of this
resubmitted R21 application are to 1) determine if activation of SIKs by a small molecule will inhibit PTH-
regulated gene expression in osteoblasts, by a. performing dose responses on PTH-stimulation of Rankl, b.
knocking down SIK2/3, c. testing the effects on other PTH-regulated genes, 2) assess if a small molecule
activator of SIKs will inhibit a high bone turnover phenotype in mice, by a. injecting a developmental model of
high bone turnover, b. injecting an adult model of high bone turnover, c. injecting an adult model of
hyperparathyroidism, and conducting complete bone analyses. In so doing, the results would be of high
impact and may lead to further preclinical studies that could form the basis for the first disease-modifying oral
treatments for patients with hyperparathyroidism, Jansen’s metaphyseal chondrodysplasia or Fibrous
Dysplasia-McCune-Albright Syndrome.
一种过度活跃的甲状旁腺激素受体1(PTHR 1)及其下游信号通路(Gs α),
涉及多种骨病,包括甲状旁腺功能亢进、詹森干骺端软骨发育不良
(due或纤维发育不良-McCune-Albright综合征(由于组成性激活PTHR 1)
活性Gs α),在遗传性疾病的情况下,可导致重大的发育和终身问题
和他们的骨架。在这三种情况下,唯一可用的治疗方法是手术或姑息治疗。蛋白激酶
A(PKA)是一种酶,其活性依赖于Gs α的活性和细胞内cAMP的水平。是
通过PTH与成骨细胞中PTHR 1的结合来调节。我们已经产生了一种诱导型成骨细胞特异性
通过胶原蛋白1-定向缺失调节亚基Prkar1a的过度活跃PKA小鼠模型,并发现
在颅骨、长骨、椎骨和尾部的尾骨中的高骨转换表型,其模拟了
PTHR1疾病我们和其他人已经表明PTH通过PKA控制基因对成骨细胞起作用
表达,部分通过盐诱导激酶(SIKs)的磷酸化抑制。这些激酶
张力磷酸化cAMP调节的转录辅激活因子(CRTC1,2和3)和组蛋白
脱乙酰酶4/5(HDAC 4/5),将它们隔离在细胞质中。在PTH作用下,PKA介导的
抑制导致CRTC2和HDAC 4/5磷酸化水平降低,
CRTC 2/3和HDAC 4/5的易位,其介导破骨细胞生成基因Rankl的转录,
调节Mmp13和抑制Sost转录。抑制、缺失或敲低sik模拟了
PTH的影响我们最近测试了几种可能激活SIKs的药物,
在分化的小鼠颅骨成骨细胞中抑制PTH诱导的Rankl转录,并发现小的
分子,9117014,作为一个"假定的" SIK激活剂,以满足这些目标。从这些培养细胞的数据,
根据体内的初步数据,我们提出了一个假设,即SIKs的小分子激活剂将逆转
骨中PTH信号通路的不良影响。因此,这一具体目标
重新提交的R21申请是为了1)确定小分子对SIKs的激活是否会抑制PTH-
调节成骨细胞中的基因表达。对Rankl的PTH刺激进行剂量响应,B.
击倒SIK2/3,c.测试对其他PTH调节基因的影响,2)评估小分子是否
在小鼠中,SIKs的活化剂将通过a.注入一种发展模式,
高骨转换,B。注射高骨转换的成人模型,c.注射一个成年的
甲状旁腺功能亢进,并进行全面的骨骼分析。这样做的结果将是高
影响,并可能导致进一步的临床前研究,可能形成的基础上,第一个疾病修饰口服
治疗甲状旁腺功能亢进、Jansen干骺端软骨发育不良或
发育不良-麦-奥二氏综合征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carole Anne Le Henaff其他文献
Carole Anne Le Henaff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
- 批准号:2021JJ40433
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
- 批准号:32001603
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
AREA国际经济模型的移植.改进和应用
- 批准号:18870435
- 批准年份:1988
- 资助金额:2.0 万元
- 项目类别:面上项目
相似海外基金
Onboarding Rural Area Mathematics and Physical Science Scholars
农村地区数学和物理科学学者的入职
- 批准号:
2322614 - 财政年份:2024
- 资助金额:
$ 38.96万 - 项目类别:
Standard Grant
TRACK-UK: Synthesized Census and Small Area Statistics for Transport and Energy
TRACK-UK:交通和能源综合人口普查和小区域统计
- 批准号:
ES/Z50290X/1 - 财政年份:2024
- 资助金额:
$ 38.96万 - 项目类别:
Research Grant
Wide-area low-cost sustainable ocean temperature and velocity structure extraction using distributed fibre optic sensing within legacy seafloor cables
使用传统海底电缆中的分布式光纤传感进行广域低成本可持续海洋温度和速度结构提取
- 批准号:
NE/Y003365/1 - 财政年份:2024
- 资助金额:
$ 38.96万 - 项目类别:
Research Grant
Point-scanning confocal with area detector
点扫描共焦与区域检测器
- 批准号:
534092360 - 财政年份:2024
- 资助金额:
$ 38.96万 - 项目类别:
Major Research Instrumentation
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326714 - 财政年份:2024
- 资助金额:
$ 38.96万 - 项目类别:
Standard Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326713 - 财政年份:2024
- 资助金额:
$ 38.96万 - 项目类别:
Standard Grant
Unlicensed Low-Power Wide Area Networks for Location-based Services
用于基于位置的服务的免许可低功耗广域网
- 批准号:
24K20765 - 财政年份:2024
- 资助金额:
$ 38.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427233 - 财政年份:2024
- 资助金额:
$ 38.96万 - 项目类别:
Standard Grant
Postdoctoral Fellowship: OPP-PRF: Tracking Long-Term Changes in Lake Area across the Arctic
博士后奖学金:OPP-PRF:追踪北极地区湖泊面积的长期变化
- 批准号:
2317873 - 财政年份:2024
- 资助金额:
$ 38.96万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427232 - 财政年份:2024
- 资助金额:
$ 38.96万 - 项目类别:
Standard Grant